PeRampanel fOr Status ePilEpticus pRophylaxis Post-cardiac Arrest
Status:
RECRUITING
Trial end date:
2026-10-20
Target enrollment:
Participant gender:
Summary
Brain injury is the main cause of death and disability for patients surviving cardiac arrest resuscitation and seizures are diagnosed in up to a third of these patients. The investigators are proposing a pilot randomized placebo-controlled clinical trial to evaluate the safety and feasibility of perampanel use for post-cardiac arrest status epilepticus (PCARSE) prevention after cardiac arrest.